Green stability-indicating RP-HPTLC approach for determining suvorexant in commercial tablet dosage forms
Abstract A novel sedative/hypnotic drug called suvorexant (SUV) is advised for treating insomnia. From a forensic standpoint, it is important medicine because of its sedative/hypnotic and depressing effects. There are no green “high-performance thin-layer chromatographic (HPTLC)” techniques for meas...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | BMC Chemistry |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13065-025-01431-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|